{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} The Explosion of a New Designer Drug, Flakka: Implications for Practice
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Purpose of Activity
To provide information on the new designer drug, flakka.Learning Objectives/Outcomes
After completing this continuing education activity you will be able to:
- Identify the pharmacokinetics and the physiological and psychological effects of flakka use.
- Examine the treatment of flakka users and the implications for healthcare providers.
- Educate your clients about the dangers of experimenting with flakka.
Disclosures
The authors and planners have disclosed no potential conflicts of interest, financial or otherwise.
Price:
$12.95
Credits:
- NAADAC 1.0 CH
Wolters Kluwer Health is a NAADAC-Approved Education Provider. Provider number 110696.
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Professions:
Addiction Counselor
Test Code: JAN1018AC
Published: Oct/Dec 2018
Expires: 10/31/2022
Required Passing Score: 14/18 (77%)
Categories:
Addiction
,
Addictions Treatment
Specialties:
Addictions
Topics:
Substance Use/Abuse